Capsid & Tail

Tags
Author

Loading issues…

  1. Evergreen turns 50: celebrating Dr. Betty Kutter’s legacyThis week, we’re proud to open up registration for the Evergreen Phage Meeting. This year’s Evergreen phage meeting will be in-person (!), absolutely packed with science and activities (!!), and will be a celebration of both Betty’s…Issue 223Jan Zheng, Jessica Sacher
  2. Launch of PhageCast: Bringing the Latest in Bacteriophage Research to Your EarsWant to hear Joana Azeredo talk about phage activity against biofilms? Or Martin Loessner speaking about L-forms and endolysins? How to set up an Appleman´s protocol with Ben Burrowes? This week a group of PhD students in the Azeredo Lab in…Issue 222David Sáez, Maria Sequeira Lopes, Alexandre Ferreira Lima
  3. C&T Round Up for April 2023!This month, we talked about analyzing qPCR results, Phage Australia's official response to the Phage UK inquiry, and got hands on with building a project with ChatGPT!Issue 221Jan Zheng
  4. Discovering coding (& building an AI tool) as a biologist, thanks to ChatGPTThis week, Jessica Sacher shows you how, as a non-coder, she got ChatGPT to help her make a chatbot that knows everything we've published across 220 Capsid & Tail blog posts (almost every week for the last 4.5 years!), how you can play with…Issue 220Jessica Sacher
  5. Phage Australia responds to UK Parliament’s phage inquiryThis week, we look at some highlights from a white paper that Phage Australia published as a response to the UK Parliament Inquiry on phage therapy.Issue 219Jan Zheng
  6. qPCR for phage therapy, part IIThis week Jessica Sacher continues her 'qPCR for phage therapy' series. She takes us through how we know if our qPCR worked, what to look for, and how to interpret how much phage/bacteria were in our samples based on the results.Issue 218Jessica Sacher
  7. C&T Round Up for March 2023!This month we featured a new phage startup out of Shanghai, and massive write-ups on lab automation, working with tabular data, and using qPCR for phage therapy.Issue 217Jan Zheng
  8. qPCR as a window into phage therapyThis week Jessica Sacher talks about how to use qPCR to count phage and bacteria in patients during phage therapy. This is part I of a multipart series.Issue 216Jessica Sacher
  9. Working with tabular dataThis week, Jan takes another detour into data-land, playing around with spreadsheets and tabular data, exploring VLOOKUP, pivot tables, and other formulas.Issue 215Jan Zheng
  10. Learning to Code as a Lab RatThis week we introduce a new guest writer, Thomas Hunt, who will write about his experiences in lab automation.Issue 214Thomas Hunt
  11. CreatiPhage – The Pioneer in ChinaAdam Yang, an intern at Shanghai Institute of Phage, interviewed the co-founder of CreatiPhage, Nannan Wu. CreatiPhage is the first company applying phage therapy to humans in China, and seeks to promote the overall development of phage…Issue 213Adam Yang
  12. C&T Round Up for February 2023!This month, we featured a new UK Phage Therapy initiative and wrote about lessons in scaling bio and how to think about data.Issue 212Jan Zheng
  13. How to think about dataThis week, Jan goes meta about data. Everyone throws around the term data, but what is it exactly? Jan explores the different kinds of data, how to work with data, and shares some ideas for keeping data neat and tidy.Issue 211Jan Zheng
  14. Lessons in scaling bio, team science & prioritiesThis week, Jessica Sacher shares learnings from setting up a pipeline for phage production/purification/QC at Phage Australia, and using it to provide phage therapy for our first 3 patients in 2022! Biggest learning: the hardest part about…Issue 210Jessica Sacher
  15. UK Establishing Phage Therapy InfrastructureThis week, Dr. Josh Jones from UK Phage Therapy drops an announcement on the establishment of a new UK-based phage therapy screening and manufacturing initiative, which will function as the UK’s national clinical phage centre.Issue 209Josh Jones
  16. C&T Round Up for January 2023!This month, we wrote an article for GARDP about phage therapy business models. For this issue, we're also revisiting a couple of gems from Dr. Paul Jaschke's lab!Issue 208Jan Zheng
  17. Investing in the future of phage therapyThis week, we're republishing an article Dr. Jon Iredell and Jessica Sacher wrote for GARDP Revive, the Global Antibiotic Research & Development Partnership.Issue 207Jon Iredell, Jessica Sacher
  18. 2023: A look aheadWell hello there, 2023! We’ve made great strides in the past year, gotten our hands wet in the lab (Jessica at least 😉), built data systems, and even delivered phages for patients. This year we aim to do a whole lot more of that! This…Issue 206Jan Zheng, Jessica Sacher
  19. Reflecting back on 2022We’re at the end of the year again, and what a whirlwind of a 2022 it’s been! Here's our annual end-of-year reflection on what we're most proud of, what we've accomplished, & those who've helped us along the way!Issue 205Jan Zheng, Jessica Sacher
  20. On Data Analytics and BiologyThis week, Jan takes a detour into data analytics! This follows up on the last informal Data Series post designing an auditable, replicable, and accessible phage data system. This time, Jan delves a bit deeper into what data analytics is,…Issue 204Jan Zheng